$CBIO News Article - Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration https://marketwirenews.com/news-releases/cata...88471.html
(0)
(0)
Gyre Therapeutics, Inc. (GYRE) Stock Research Links